MARINUS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to Q1 2024.
  • Marinus Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $257K.
  • Marinus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $26.6M, a 78.7% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $125M, a 202% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $41.3M, a 62.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

MARINUS PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $257K +$431K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$174K -$31.3M -101% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $31.1M +$31M +32330% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $96K -$21K -17.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $117K +$200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 -$83K +$110K +57% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q1 2018 -$193K -$1.83M -112% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $1.64M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02

MARINUS PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $26.6M -$98.1M -78.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $125M +$83.4M +202% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $41.3M -$67.9M -62.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $109M +$41.2M +60.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $68M +$25.8M +61.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $42.1M -$5.47M -11.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $47.6M +$49.8M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$2.17M -$30.6M -108% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $28.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.